RET V804M-IN-1
RET V804M-IN-1 is a selective kinase inhibitor targeting wild-type RET with an IC50 of 20 nM, while also potently inhibiting the RET (V804M) gatekeeper mutant. This compound is a valuable chemical probe for investigating RET-driven oncogenesis in both cellular and biochemical assays.
Product Specifications
CAS Number
2414909-94-5
Product Name Alternative
RETV804M, RETV804M kinase inhibitor, RET V804M IN 1, RET V804MIN1, RET V-804M-IN-1, RET V804M-IN-1, RET, cRET, Inhibitor, inhibit, LUN 09945, LUN09945, LUN-09945
Field of Research
Cell Biology, Signal Transduction
Purity
96.97% (May vary between batches)
Solubility
DMSO:120 mg/mL (348.46 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (11.62 mM)
Smiles
NC (=O) c1ccc (cc1) -c1cnn2ccc (NCc3cccnc3) nc12
Molecular Formula
C19H16N6O
Molecular Weight
344.37
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15128414 1 Vial
Lentiviral human ZMYM4 shRNA (UAS) - Lentiviral human ZMYM4 shRNA (UAS, iRFP) (25)
Sign In for Pricing
View Details 
47970121 3x 1.0µg DNA
TRNAD5 CRISPRa sgRNA lentivector (set of three targets)(Human)
Sign In for Pricing
View Details 168889-AF-ML405 100 µL
VEGF-R2 (CD309, Fetal liver kinase 1 (FLK-1), KDR, Kinase insert domain receptor (a type III receptor tyrosine kinase), KRD1, Ly73, Protein tyrosine kinase receptor FLK1, Protein-tyrosine kinase receptor flk-1, Vascular endothelial growth factor receptor 2) (BSA & Azide Free) (MaxLight 405) discontinued
Sign In for Pricing
View Details